THE EFFECT OF APROTININ ON BLOOD PRODUCT REQUIREMENTS DURING ORTHOTOPIC LIVER-TRANSPLANTATION

被引：0
|
作者：
BECHSTEIN, WO
RIESS, H
NEUHAUS, P
HIMMELREICH, G
STEFFEN, R
SLAMA, KJ
ROSSAINT, R
BLUMHARDT, G
机构：
来源：
CLINICAL TRANSPLANTATION | 1991年 / 5卷 / 06期
关键词：
LIVER TRANSPLANTATION; BLOOD TRANSFUSION; APROTININ;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The effect of aprotinin, a protease inhibiting agent, on blood product requirements in liver transplantation was investigated in a prospective, open, non-randomized study. From September 1988 until January 1990, 60 consecutive liver transplantations were performed in 56 adult recipients. The first 10 patients (group I) were treated without aprotinin; for the next 50 transplantations (group II) aprotinin was applied in a total dose of 1.5-2.0 mio units i.v. intraoperatively. During primary transplants a mean of 9.7 +/- 5.5 units packed red blood cells (RBC) were substituted in group I vs. 7.5 +/- 4.6 units RBC in group II (n.s.). Fresh frozen plasma was substituted with 10.4 +/- 6.2 (group I) vs. 9.1 +/- 6.7 (group II) units (n.s.). Adverse effects of aprotinin were not observed. The trend towards decreased transfusion requirements and the observation of reduced fibrinolysis prompted us to continue routine use of aprotinin in liver transplantation.
引用
收藏
页码：422 / 426
页数：5
相关论文
共 50 条
  • [1] BLOOD REQUIREMENTS REDUCTION IN ORTHOTOPIC LIVER-TRANSPLANTATION WITH APROTININ
    MONEDERO, P
    CARRERA, J
    CATALA, J
    CARRASCOSA, F
    ARROYO, JL
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1993, 70 : 50 - 50
  • [2] APROTININ AND REDUCTION OF BLOOD-LOSS AND TRANSFUSION REQUIREMENTS IN ORTHOTOPIC LIVER-TRANSPLANTATION
    MALLETT, SV
    COX, D
    BURROUGHS, AK
    ROLLES, K
    [J]. LANCET, 1990, 336 (8719): : 886 - 887
  • [3] APROTININ IN ORTHOTOPIC LIVER-TRANSPLANTATION
    GARCIA, L
    SABATE, A
    DOMENECH, P
    BROTONS, FM
    DRUDIS, R
    JAURRIETA, E
    [J]. TRANSPLANTATION PROCEEDINGS, 1995, 27 (04) : 2290 - 2291
  • [4] APROTININ IN ORTHOTOPIC LIVER-TRANSPLANTATION
    BECHSTEIN, WO
    RIESS, H
    BLUMHARDT, G
    HIMMELREICH, G
    JOCHUM, M
    GERLACH, H
    ROSSAINT, R
    KECK, H
    NEUHAUS, P
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1993, 19 (03): : 262 - 267
  • [5] APROTININ AND ORTHOTOPIC LIVER-TRANSPLANTATION
    MALLETT, SV
    ALCOCK, R
    COX, D
    DAVIDSON, B
    ROLLES, K
    [J]. LANCET, 1992, 340 (8817): : 493 - 493
  • [6] EFFECTIVENESS OF APROTININ IN ORTHOTOPIC LIVER-TRANSPLANTATION
    SUAREZ, M
    SANGRO, B
    HERRERO, JI
    PICARDI, A
    PARAMO, JA
    QUIROGA, J
    PARDO, F
    ACIENFUEGOS, J
    CARRERA, J
    HIDALGO, F
    CARRASCOSA, F
    ROCHA, E
    PRIETO, J
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1993, 19 (03): : 292 - 296
  • [7] APROTININ EFFICACY ON INTRAOPERATIVE BLEEDING AND TRANSFUSION REQUIREMENTS IN ORTHOTOPIC LIVER-TRANSPLANTATION
    PATRASSI, GM
    VIERO, M
    SARTORI, MT
    DESILVESTRO, G
    ROSSARO, L
    BURRA, P
    NOLLI, ML
    PICCINNI, P
    BASSI, N
    [J]. TRANSFUSION, 1994, 34 (06) : 507 - 511
  • [8] EFFECT OF APROTININ ON FIBRINOLYSIS DURING ORTHOTOPIC LIVER-TRANSPLANTATION - A PRELIMINARY-STUDY
    LEQUERREC, A
    DERLON, A
    DESHAYES, JP
    TARTIERE, J
    SEGOL, P
    BRICARD, H
    THOMAS, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1089 - 1089
  • [9] HEMODYNAMIC-EFFECTS OF APROTININ DURING ORTHOTOPIC LIVER-TRANSPLANTATION
    COTTAM, S
    DOWNING, A
    BEARD, C
    POTTER, D
    [J]. HEPATOLOGY, 1993, 18 (03) : 735 - 735
  • [10] DOES APROTININ REALLY REDUCES BLOOD-LOSS DURING ORTHOTOPIC LIVER-TRANSPLANTATION
    ICKX, B
    PRADIER, O
    DEGROOTE, F
    HENDRICE, C
    GELIN, M
    VANDESTADT, TJ
    CAPEL, P
    [J]. HEPATOLOGY, 1993, 18 (03) : 740 - 740
12345